journal article·2020-05-11

Synthesis, Characterization, and 3D Printing of an Isosorbide-Based, Light-Curable, Degradable Polymer for Potential Application in Maxillofacial Reconstruction

Nazanin Owji, Alaa Aldaadaa, Jae-Ryung Cha, Taleen Shakouri, Elena García-Gareta, Hae-Won Kim, Jonathan C. Knowles

Publisher page

Abstract

Although emergence of bone tissue engineering techniques has revolutionized the field of maxillofacial reconstruction, the successful translation of such products, especially concerning larger sized defects, still remains a significant challenge. Light-curable methacrylate-based polymers have ideal properties for bone repair. These materials are also suitable for 3D printing which can be applicable for restoration of both function and aesthetics. The main objective of this research was to synthesize a mechanically stable and biologically functional polymer for reconstruction of complex craniofacial defects. The experimental work initially involved synthesis of (((3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl)bis(oxy))bis(ethane-2,1-diyl)bis((4-methyl-3-oxopent-4-en-1-yl)carbamate), CSMA-1, and ((((((((((((3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl)bis(oxy))bis(ethane-2,1 diyl))bis(oxy))bis(carbonyl))bis(azanediyl))bis(methylene))bis(3,3,5-trimethylcyclohexane-5,1-diyl))bis(azanediyl))bis(carbonyl))bis(oxy))bis(ethane-2,1-diyl)bis(2-methylacrylate), CSMA-2; nuclear magnetic resonance analysis confirmed formation of the monomers, and composite samples were fabricated respectively by exposing 11 mm diameter discs to blue light. Modulus of elasticity was determined using a biaxial flexural test and the values were found to be between 1 and 3 GPa in CSMA-1, CSMA-2, and their composites. In vitro cell culture, using human bone marrow-derived mesenchymal stem cells, confirmed nontoxicity of the samples and finally 3D printing allowed direct photo-polymerization and setting of the bio ink into a 3D construct.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Additive Manufacturing and 3D Printing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

RAFT, Regenerative Biomaterials Group, The RAFT Institute, Mount Vernon Hospital, Northwood HA6 2RN, U.K.

Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 330-714, Republic of Korea

Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31114, Republic of Korea

UCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Cheonan 31114, Republic of Korea

The Discoveries Centre for Regenerative and Precision Medicine, University College London, UCL Campus, London WC1E 6BT, U.K.

Funding

National Research Foundation of Korea · Restoration of Appearance and function Trust

References (44)

Show source-provided references
1. 10.1016/j.joms.2011.06.22510.1016/j.joms.2011.06.225 ↗
2. Visser A. · Int. J. Oral Maxillofac. Implant. · 2008 · 23 · 89
3. 10.1111/ors.1214310.1111/ors.12143 ↗
4. UK Cr · 2017
5. 10.1016/j.joms.2014.12.00510.1016/j.joms.2014.12.005 ↗
6. 10.1002/micr.2209010.1002/micr.22090 ↗
7. 10.1097/01.scs.0000179662.38172.dd10.1097/01.scs.0000179662.38172.dd ↗
8. Lanza R. · 2011
9. 10.1021/nn507488s10.1021/nn507488s ↗
10. 10.1016/j.joms.2015.04.01910.1016/j.joms.2015.04.019 ↗
11. 10.1016/j.bioactmat.2016.11.00110.1016/j.bioactmat.2016.11.001 ↗
12. 10.1016/j.dental.2019.02.02310.1016/j.dental.2019.02.023 ↗
13. 10.1039/c0jm04502k10.1039/c0jm04502k ↗
14. 10.11113/jt.v76.571710.11113/jt.v76.5717 ↗
15. Cheng, Y. L.; Kao, H. L. Study on Visible-light-curable Polycarprolactone and Poly(ethylene glycol) diacrylate for LCD-projected Maskless Additive Manufacturing System. Light Manipulating Organic Materials and Devices II, 2015; Vol. 9564.10.1117/12.2188047 ↗
16. 10.1016/j.biomaterials.2005.03.01810.1016/j.biomaterials.2005.03.018 ↗
17. 10.1023/b:abme.0000017544.36001.8e10.1023/b:abme.0000017544.36001.8e ↗
18. 10.1016/j.mattod.2013.11.01710.1016/j.mattod.2013.11.017 ↗
19. 10.1002/app.3883210.1002/app.38832 ↗
20. 10.1016/j.msec.2014.03.04610.1016/j.msec.2014.03.046 ↗
21. 10.1016/j.actbio.2010.07.01210.1016/j.actbio.2010.07.012 ↗
22. Carlsson E. · 201510.1155/2015/594284 ↗
23. 10.1016/j.msec.2015.07.01610.1016/j.msec.2015.07.016 ↗
24. 10.1016/j.msec.2017.02.17010.1016/j.msec.2017.02.170 ↗
25. 10.1038/s41598-018-23577-y10.1038/s41598-018-23577-y ↗
26. 10.1016/j.carbpol.2018.06.09310.1016/j.carbpol.2018.06.093 ↗
27. 10.1002/term.189610.1002/term.1896 ↗
28. 10.1016/j.progpolymsci.2015.02.00410.1016/j.progpolymsci.2015.02.004 ↗
29. Niaounakis M. · 2013 · 1
30. 10.1016/j.jmbbm.2015.09.01610.1016/j.jmbbm.2015.09.016 ↗
31. 10.1016/j.actbio.2017.02.04410.1016/j.actbio.2017.02.044 ↗
32. Carrier O. · 2015 · 1510.1016/B978-0-12-800722-8.00002-3 ↗
33. 10.1021/acsbiomaterials.5b0019410.1021/acsbiomaterials.5b00194 ↗
34. 10.3390/s12091234710.3390/s120912347 ↗
35. 10.1038/srep2336710.1038/srep23367 ↗
36. 10.1016/j.matchar.2014.08.01710.1016/j.matchar.2014.08.017 ↗
37. 10.1177/204173141243955510.1177/2041731412439555 ↗
38. 10.1016/j.actbio.2011.08.00810.1016/j.actbio.2011.08.008 ↗
39. 10.1016/j.archoralbio.2016.07.01010.1016/j.archoralbio.2016.07.010 ↗
40. 10.1007/s13346-015-0236-010.1007/s13346-015-0236-0 ↗
41. 10.1177/204173141877681910.1177/2041731418776819 ↗
42. 10.1177/204173141882479710.1177/2041731418824797 ↗
43. 10.1016/j.actbio.2018.08.02610.1016/j.actbio.2018.08.026 ↗
44. 10.1177/204173141877090910.1177/2041731418770909 ↗